Liquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 783, Issue 1, 2003, Pages 273-285

  Xu, Yan ^a   Grem, Jean L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

5 Deoxy 5 fluorocytidine; 5 Deoxy 5 fluorouridine; Capecitabine

Indexed keywords

IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PLASMA APPLICATIONS;

ELECTROSPRAY IONIZATION;

BIOMEDICAL ENGINEERING;

5' DEOXY 5 FLUOROCYTIDINE; CAPECITABINE; CLOXURIDINE; CYTIDINE DERIVATIVE; DOXIFLURIDINE; OXALIPLATIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ANALYTIC METHOD; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DYNAMICS; ELUTION; HUMAN; IONIZATION; MASS SPECTROMETRY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; COLORECTAL TUMOR; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY;

ANTIMETABOLITES, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; HUMANS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0037419491     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(02)00674-8     Document Type: Article

References (10)

1. O'Shaughnessy J.A., Blum J., Moiseyenko V., Jones S.E., Miles D., Bell D., Rosso R., Mauriac L., Osterwalder B., Burger H.U., Laws S. Ann. Oncol. 12:2001;1247.
2. Blum J.L., Jones S.E., Buzdar A.U., LoRusso P.M., Kuter I., Vogel C., Osterwalder B., Burger H.U., Brown C.S., Griffin T. J. Clin. Oncol. 17:1999;485.
3. Van Cutsem E., Twelves C., Cassidy J., Allman D., Bajetta E., Boyer M., Bugat R., Findlay M., Frings S., Jahn M., McKendrick J., Osterwalder B., Perez-Manga G., Rosso R., Rougier P., Schmiegel W.H., Seitz J.F., Thompson P., Vieitez J.M., Weitzel C., Harper P. J. Clin. Oncol. 19:2001;4097.
4. Hoff P.M., Ansari R., Batist G., Cox J., Kocha W., Kuperminc M., Maroun J., Walde D., Weaver C., Harrison E., Burger H.U., Osterwalder B., Wong A.O., Wong R. J. Clin. Oncol. 19:2001;2282.
5. Miwa M., Ura M., Nishida M., Sawada N., Ishikawa T., Mori K., Shimma N., Umeda I., Ishitsuka H. Eur. J. Cancer. 34:1998;1274.
6. Grem J.L. Invest. New Drugs. 18:2000;299.
7. Budman D.R., Meropol N.J., Reigner B., Creaven P.J., Lichtman S.M., Berghorn E., Behr J., Gordon R.J., Osterwalder B., Griffin T. J. Clin. Oncol. 16:1998;1795.
8. Cassidy J., Dirix L., Bissett D., Reigner B., Griffin T., Allman D., Osterwalder B., Van Oosterom A.T. Clin. Cancer Res. 4:1998;2755.
9. Reigner B., Verweij J., Dirix L., Cassidy J., Twelves C., Allman D., Weidekamm E., Roos B., Banken L., Utoh M., Osterwalder B. Clin. Cancer Res. 4:1998;941.
10. Reigner B., Clive S., Cassidy J., Jodrell D., Schulz R., Goggin T., Banken L., Roos B., Utoh M., Mulligan T., Weidekamm E. Cancer Chemother. Pharmacol. 43:1999;309.